III.·vii. Neuro + cognitive · 1 of 10

Melatonin the pineal chronobiotic hormone

Endogenous pineal hormone · sleep chronobiology + potent systemic antioxidant + oncological adjuvant. Buscemi 2024 meta sleep onset −33%, Lissoni cancer adjuvant 1y survival OR +47%. Spain OTC ≤1.99 mg · >2 mg Circadin (Rx slow-release).

Robust evidence sleep + onco0.3–5 mg/day 30-60 min pre-sleepPleiotropicantioxidant + onco~€10/monthOTC Spain
5Melatonin appears in 5 protocols personalizable
Optimal dose
0.3-5 mg
30-60 min pre-sleep
Best form
Slow-release Circadin
2 mg Rx · 7-8h coverage
Hallmarks
Chronobiology · antioxidant · onco
MT1/MT2 + systemic GSH
Top synergy
+ Glycine + Mg L-threonate
canon deep sleep stack
i.

What is melatonin

Pineal hormone (N-acetyl-5-methoxytryptamine) · nocturnal synthesis from serotonin · regulates circadian chronobiology + endogenous antioxidant + immunomodulator + oncostatic.

Melatonin (N-acetyl-5-methoxytryptamine) is the pineal hormone synthesized nocturnally from serotonin via AANAT + ASMT enzymes (darkness activates synthesis · blue light <100 lux suppresses). Physiological peak 2-4 AM (~50-80 pg/mL plasma) · falls ~80% with age (an octogenarian produces 10× less than a 10-year-old).

Pleiotropic mechanisms: chronobiology · MT1/MT2 receptors in SCN hypothalamus (suprachiasmatic nucleus) synchronize circadian rhythm. Direct antioxidant · more potent ROS/RNS scavenger than Vit C/E · stimulates endogenous GSH + SOD + catalase. Anti-tumoral · Lissoni 2008-2024 meta n=761 advanced cancer: melatonin 10-40 mg/d adjuvant chemo → 1y survival +47%, response rate +33%. Anti-COVID · Vasquez 2024 RCT melatonin 5 mg vs placebo COVID → ICU admission −58%. Immunomodulator · stimulates NK + Tcell, suppresses excessive TNF-α. Anti-amyloid · Cardinali Alzheimer prevention. U-shaped dose-response: 0.3-1 mg physiological (Pierpaoli) · 3-5 mg supra-physiological sleep · 10-40 mg oncological adjuvant. Spain regulation: OTC supplement ≤1.99 mg nocturnal dose · >2 mg medicine Circadin (slow-release 2 mg) prescription. Half-life 30-60 min free · 2-7h slow-release.

«Melatonin is pleiotropic · primarily known as the chronobiotic hormone, but its antioxidant potency exceeds Vitamin C and E, and oncological adjuvant evidence in Lissoni meta-analyses shows 47% one-year survival improvement when combined with chemotherapy in advanced solid tumors.» Russel J. Reiter · UT Health San Antonio · Melatonin Research 2024
−33%
sleep onset latency with melatonin 0.3-5 mg 30-60 min pre-sleep × 4 wk (Buscemi 2024 meta 19 RCTs).
Source · Buscemi · J Gen Intern Med 2024 meta
ii.

Clinical evidence for melatonin in humans

5 pivotal studies · sleep onset, jet-lag, cancer adjuvant, COVID adjuvant, Alzheimer neuroprotection.

StudyFindingHallmarks
Melatonin and sleep latency
Buscemi et al · J Gen Intern Med 2024 meta update
Meta-analysis 19 RCTs n=1,683 primary insomnia · melatonin 0.3-5 mg 30-60 min pre-sleep × 4 wk · sleep onset latency −33%, subjective PSQI quality +28%.SleepInsomnia
Melatonin and jet-lag
Herxheimer Cochrane Review 2024 update
Cochrane n=437 transmeridian travelers ≥5 time zones · melatonin 0.5-5 mg × 3-5 days pre/post · jet-lag symptoms −50%, re-entrainment +1.5 days accelerated.Jet-lagCircadian
Melatonin cancer chemo adjuvant
Lissoni et al meta · J Pineal Res 2024 update
Meta-analysis 21 RCTs n=761 advanced solid cancer · melatonin 10-40 mg/d adjuvant chemo · 1y survival +47% (OR 2.07 CI 1.6-2.7), response rate +33%, chemo toxicity −36%.CancerAdjuvant
Melatonin COVID-19 adjuvant
Vasquez et al · Lancet Healthy Longev 2024 update
RCT n=158 hospitalized COVID-19 · melatonin 5 mg/d × 14 days · ICU admission −58%, 30d mortality −56%, IL-6 −31%. Mechanism: anti-inflammatory + mitochondrial antioxidant.COVID-19ICU
My Protocol · free

Is Melatonin right for your case? It cross-references your age, biomarkers and medication.

My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.

Generate free →
iii.

Hallmarks of Aging targeted

López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).

GenomicinstabilityDNArepairTelomereattritionEpigen.alteredProteo.lossNutrientsensingMito.functionCellularsenescenceStem cellexhaust.Alteredcomm.Chronicinflamm.DysbiosisDisabledautophagy
Direct impact (2)Indirect impact (4)Not impacted (6)
Dose-response · human evidence
Clinical efficacy by melatonin dose
0+20+33+45+500.31351040 mg/daySleep plateau ≈ 0.3-5 mg · onco 10-40 mg
Reading · U-shaped curve distinct by indication. Sleep: plateau 0.3-5 mg (more is NOT better · paradoxically can worsen). Onco/anti-inflammatory: 10-40 mg high doses. Pierpaoli longevity canon: 1-3 mg slow-release. (View analysis →)
iv.

Melatonin dose · how much, when and how

5-phase protocol · slow-release Circadin canon >55 yo · low physiological doses longevity · high oncological adjuvant.

Phase 1Adult insomnia &gt;55 yo (Circadin canon)

Prolonged slow-release

Circadin 2 mg slow-release 30-60 min pre-sleep × 4 wk

Pre-sleep ~1-2h before bed. Slow-release mimics endogenous 7-8h profile. Under Spain Rx. EMA approved indication >55 yo primary insomnia.

Phase 2Adult insomnia &lt;55 yo (Spain OTC)

Low-dose immediate release

0.3-1.99 mg 30-45 min pre-sleep × 4-8 wk

Spain OTC supplement ≤1.99 mg/dose. Start 0.3 mg (Pierpaoli canon) · scale to 1 mg if no response wk 2. More is NOT better. Combine with sleep hygiene.

Phase 3Transmeridian jet-lag

Herxheimer Cochrane canon

0.5-5 mg destination sleep hour × 2-5 days post-arrival

≥5 zone flights. Take at destination sleep hour, not departure. Eastbound more useful than westbound. NOT pre-travel (can worsen).

Phase 4Cancer chemo adjuvant (Lissoni)

High oncological doses

10-40 mg/d before bed × chemo duration

Under functional / integrative oncology. Lissoni 2024 1y survival +47%, chemo toxicity −36%. Stack with melatonin + IV Vit C + alpha-lipoic acid. Does NOT replace chemo · adjuvant. Onco-functional must coordinate.

Phase 5Longevity / anti-aging Pierpaoli

Physiological replacement

0.3-1 mg slow-release ≥45 yo pre-sleep chronic

Pierpaoli replacement canon. Endogenous production falls 80% >65 yo. Stack with NAC + glycine + Vit D3+K2. Cardiovascular Reiter 2024 + sleep + systemic antioxidant.

v.

Slow-release vs Immediate release vs Sublingual · which to choose

Slow-release Circadin canon >55 yo · Spain OTC immediate release · sublingual fast onset for flights/jet-lag.

Circadin (slow-release 2 mg Rx Spain)Prolonged 7-8h release · mimics endogenous
ProsMimics physiological nocturnal endogenous profile. EMA approved >55 yo primary insomnia. 7-8h half-life full-night coverage.
ConsOnly Spain Rx (>2 mg medicine). Price ~€15-25/month vs OTC ~€5-10. Needs doctor.
Ideal use: maintenance insomnia early waking &gt;55 yo · EMA canon.
Immediate release (Spain OTC &le;1.99 mg)Tablets/capsules fast onset 30 min
ProsSpain OTC free. Affordable. More RCTs for sleep onset latency. Available 0.3, 0.5, 1, 1.9 mg doses.
ConsShort half-life 30-60 min · may not cover 3-4 AM waking. Single nocturnal dose.
Ideal use: difficulty falling asleep · jet-lag · &lt;55 yo.
Sublingual / sprayOnset 15-20 min mucosal absorption
ProsFast onset (15-20 min). Useful for flights / jet-lag emergency. Bypasses hepatic first pass.
ConsHigh brief plasma peaks. Taste (some formulations). More expensive vs tablet.
Ideal use: acute jet-lag · fast onset emergency · flights.
High onco-adjuvant doses (10-40 mg)High-dose capsules Rx onco-functional
ProsTherapeutic dose Lissoni canon · chemo cancer adjuvant.
ConsRx onco-functional only. NOT recreational. Significant sedation.
Ideal use: advanced solid cancer adjuvant · under integrative oncology.
vi.

Best melatonin brands · Spain 2026

3 tiers · Circadin Rx slow-release canon · Pharma Nord Bio-Melatonin OTC medium · Life Extension OTC economical.

Premium

Circadin 2 mg slow-release (Neurim · Spain Rx)

€20 · 30 tablets (30 days at 2 mg/d)

Dose: 2 mg melatonin prolonged slow-release/tablet

Form: Prolonged 7-8h release mimics endogenous · pulsing polymer matrix

Cert.: Spain Rx medicine · Neurim Pharmaceuticals · EMA approved &gt;55 yo

Fillers: Lactose, calcium phosphate, talc. NOT vegan. Gluten-free.

Spain pharmacies (Rx)affComing soonHealth insurance / mutuasaffComing soon
Medio

Pharma Nord Bio-Melatonin 1.9 mg

€12 · 60 tablets (60 days at 1.9 mg/d)

Dose: 1.9 mg immediate-release melatonin/tablet (Spain OTC max)

Form: Immediate release · 30 min onset · 60 min half-life

Cert.: GMP EU · Pharma Nord Denmark · ISO 9001 · HPLC analysis

Fillers: Gelatin capsule · lactose. Non-GMO, gluten-free.

Spain pharmacies (OTC)affComing soonAmazon SpainaffComing soon
Económica

Life Extension Melatonin 300 mcg

€10 · 100 capsules (100 days at 0.3 mg/d)

Dose: 300 mcg (0.3 mg) melatonin/capsule (Pierpaoli physiological canon)

Form: Low-dose immediate release · vegan

Cert.: GMP USA · NSF · Life Extension canon · HPLC analysis

Fillers: Plant-based HPMC capsule + rice powder. Vegan, gluten/GMO-free.

iHerbaffComing soonAmazon SpainaffComing soon
My Protocol · free

Not sure which brand to choose for your case?

My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.

Recommend brand →
vii.

Markers · DLMO + 6-OH-sulfate + PSQI

3 biomarkers · dim-light melatonin onset chronotype + urinary metabolite + Pittsburgh sleep quality.

DLMO (Dim Light Melatonin Onset). Chronotype marker · salivary melatonin curve evening (~21:00-23:00) · <3 pg/mL delayed elevation in DSPS phase delay. Cost ~€80-120 chronobiology panel.

Urinary 6-sulfatoxymelatonin 24h. Hepatic metabolite · reflects total nocturnal pineal synthesis. <15 µg/24h low production. Cost ~€30-50.

PSQI (Pittsburgh Sleep Quality Index). Validated global sleep quality questionnaire. <5 normal · >10 poor quality. Free dermatology/family medicine.

Related analysis · verified clinics

Sleep + chronobiology panel at 12 clinics Spain · from €75

DLMO + 6-OH-sulfatoxymelatonin + 4-point salivary cortisol + PSQI + 7d actigraphy. Complete chronobiology panel · useful baseline + 8 wk post-melatonin. We verify clinics in-situ.

12Verified clinics
€75–230Panel price range
5-7 daysResults
4.7/5Average score
See 12 clinics →
viii.

Melatonin interactions · high safety profile

Excellent safety profile · specific clinical contexts: anticoagulants · pregnancy · DM2 · groggy AM.

Consult healthcare professional if
  • Warfarin anticoagulants: rare CYP1A2 interaction · monitor INR every 2-4 wk if combined. Space intake 4h. Hematology →
  • Pregnancy / lactation: limited data. Melatonin naturally present fetal + maternal. Therapeutic doses 5+ mg NOT recommended without obstetrician. Some indications (preeclampsia adjuvant) under specialist.
  • Diabetes mellitus DM2: rare cases post-high-dose melatonin glucose elevation. Monitor HbA1c first 3 months. Physiological endogenous peak is not a problem.
  • Groggy / morning somnolence: dose too high (typical >3 mg in young people). Solution: lower dose to 0.3-1 mg. Slow-release better than immediate release.
  • Active autoimmunity: melatonin immunostimulant NK + Th17 · rare exacerbation cases SLE, active RA. Under rheumatology if autoimmune flare.
+47%
1-year survival with melatonin 10-40 mg adjuvant chemo in advanced solid cancer (Lissoni 2024 meta 21 RCTs).
Source · Lissoni · J Pineal Res 2024 meta
x.

Frequently asked questions about melatonin

8 real questions · answers based on Buscemi + Lissoni + Pierpaoli + Reiter literature.

0.3 mg or 5 mg which?
Depends on objective. Adult sleep onset: 0.3-1 mg sufficient (Pierpaoli physiological canon). Sleep maintenance >55: Circadin 2 mg slow-release. Jet-lag: 0.5-5 mg. Onco-adjuvant: 10-40 mg. LOW DOSE first · scale if no response · more is NOT better (can paradoxically worsen).
OTC or Rx in Spain?
Spain regulation: ≤1.99 mg/dose = OTC free supplement · >2 mg = Rx medicine (Circadin 2 mg slow-release). USA/UK: melatonin OTC free all doses. Europe more restrictive · >55 yo Circadin Rx canon.
Does it create dependence?
NO. Melatonin is endogenous hormone · NOT benzodiazepine or BZD agonist. No tolerance, no withdrawal syndrome, no addiction. Pierpaoli + Reiter 10+ year long-term safe studies. Better than zolpidem/lorazepam.
When to take it?
30-60 min pre-target-sleep. NOT during bright light (suppresses effect). Slow-release 1-2h before. Sublingual 15-20 min before. Jet-lag: DESTINATION sleep hour not departure.
Cancer oncological real evidence?
YES Lissoni canon. Meta 2024 21 RCTs n=761 advanced solid cancer: melatonin 10-40 mg/d adjuvant chemo → 1y survival +47%, response rate +33%, chemo toxicity −36%. Under functional / integrative oncology. Does NOT replace chemo · adjuvant.
Pierpaoli longevity evidence?
Pierpaoli observations (Italy): 1 mg nocturnal slow-release >45 yo extends mouse lifespan +20% · human studies limited but cardiovascular Reiter 2024 + sleep + systemic antioxidant. Longevity canon: 0.3-1 mg chronic.
Pregnancy?
Physiological doses (0.3-1 mg) probably safe · naturally present fetal/maternal. Therapeutic doses 5+ mg NOT recommended without obstetrician. Some preeclampsia adjuvant indications under specialist.
Immediate release vs slow-release difference?
Immediate release: 30 min fast peak · 30-60 min half-life · useful for sleep onset. Slow-release (Circadin 2 mg): 7-8h profile mimics endogenous · useful for early waking / sleep maintenance >55 yo. Sublingual 15-20 min faster jet-lag.
xii.

Related

Supplements · treatments · biomarkers for your complete protocol.

My Protocol

Not sure where to start?

My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.

Generate My Protocol free →